Standard
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes. / Heimburger, Sebastian M.; Brønden, Andreas; Johansen, Nicklas J.; Dejgaard, Thomas F.; Vilsboll, Tina; Knop, Filip K.
I:
Expert Opinion on Pharmacotherapy, Bind 20, Nr. 5, 2019, s. 501-510.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Heimburger, SM
, Brønden, A, Johansen, NJ, Dejgaard, TF
, Vilsboll, T & Knop, FK 2019, '
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes',
Expert Opinion on Pharmacotherapy, bind 20, nr. 5, s. 501-510.
https://doi.org/10.1080/14656566.2019.1571040APA
Heimburger, S. M.
, Brønden, A., Johansen, N. J., Dejgaard, T. F.
, Vilsboll, T., & Knop, F. K. (2019).
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
Expert Opinion on Pharmacotherapy,
20(5), 501-510.
https://doi.org/10.1080/14656566.2019.1571040Vancouver
Heimburger SM
, Brønden A, Johansen NJ, Dejgaard TF
, Vilsboll T, Knop FK.
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
Expert Opinion on Pharmacotherapy. 2019;20(5):501-510.
https://doi.org/10.1080/14656566.2019.1571040Author
Heimburger, Sebastian M. ; Brønden, Andreas ; Johansen, Nicklas J. ; Dejgaard, Thomas F. ; Vilsboll, Tina ; Knop, Filip K. / The efficacy and safety of exenatide once weekly in patients with type 2 diabetes. I: Expert Opinion on Pharmacotherapy. 2019 ; Bind 20, Nr. 5. s. 501-510.
Bibtex
@article{ddfe9fd873704f1fa3dc60199ecbf622,
title = "The efficacy and safety of exenatide once weekly in patients with type 2 diabetes",
keywords = "Exenatide extended-release, exenatide QW, glucagon-like peptide 1, glucagon-like peptide 1 receptor agonist, glycaemic control, type 2 diabetes, cardiovascular adverse events",
author = "Heimburger, {Sebastian M.} and Andreas Br{\o}nden and Johansen, {Nicklas J.} and Dejgaard, {Thomas F.} and Tina Vilsboll and Knop, {Filip K.}",
year = "2019",
doi = "10.1080/14656566.2019.1571040",
language = "English",
volume = "20",
pages = "501--510",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor & Francis",
number = "5",
}
RIS
TY - JOUR
T1 - The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
AU - Heimburger, Sebastian M.
AU - Brønden, Andreas
AU - Johansen, Nicklas J.
AU - Dejgaard, Thomas F.
AU - Vilsboll, Tina
AU - Knop, Filip K.
PY - 2019
Y1 - 2019
KW - Exenatide extended-release
KW - exenatide QW
KW - glucagon-like peptide 1
KW - glucagon-like peptide 1 receptor agonist
KW - glycaemic control
KW - type 2 diabetes
KW - cardiovascular adverse events
U2 - 10.1080/14656566.2019.1571040
DO - 10.1080/14656566.2019.1571040
M3 - Journal article
C2 - 30730773
VL - 20
SP - 501
EP - 510
JO - Expert Opinion on Pharmacotherapy
JF - Expert Opinion on Pharmacotherapy
SN - 1465-6566
IS - 5
ER -
